Keymed Biosciences's change in inventory for the quarter that ended in Jun. 2024 was HK$-29.7 Mil. It means Keymed Biosciences's inventory
increased by HK$29.7 Mil
from Dec. 2023 to Jun. 2024 .
Keymed Biosciences's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-13.0 Mil. It means Keymed Biosciences's inventory
increased by HK$13.0 Mil
from Dec. 2022 to Dec. 2023 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Keymed Biosciences's Days Inventory for the quarter that ended in Jun. 2024 was 3,448.37.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Keymed Biosciences's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.05.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Keymed Biosciences's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 1.29.
Keymed Biosciences Change In Inventory Historical Data
The historical data trend for Keymed Biosciences's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Keymed Biosciences Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-3.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Keymed Biosciences (HKSE:02162) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Keymed Biosciences's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Keymed Biosciences's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Keymed Biosciences Change In Inventory Related Terms
Thank you for viewing the detailed overview of Keymed Biosciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02162 has been successfully added to your 